Zilarvir (GPO)
1421
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection

1421
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection